Valentx

Adjustable Endoluminal bypass sleeve for obesity treatment

placeCarpinteria, California, United States calendar_todayFounded 2002 groups22 employees language valentx.com

Innovation

21 patent families (14 granted) — focus: Human necessities; filing pace dormant. Cited 13,493 times.

YearFilings
20124
20134
20147
20154
20164
20175
20183
20194
20201

Investor mix

8 investors on record; lead investors include EDF Ventures, SV Health Investors.

Investor typeCountShare
Venture capital563%
Private equity113%
Other / undisclosed225%
Coming soon